Fusion of this gene to members of the ETS family of transcription factors, in particular ERG or ETV1, leads to overexpression of the oncogenes in a large portion of prostate cancer cases, but not in benign prostate samples, in an androgen-dependent manner. Here, ERG is linked to prostate carcinoma.